China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · IEX Real-Time Price · USD

0.990

-0.190 (-16.10%)

At close: Apr 18, 2024, 4:00 PM

1.055

+0.065 (6.57%)

Pre-market: Apr 19, 2024, 4:40 AM EDT

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	17.37	15.57	13.36	7.29	9.29	0.66	0.07
Short-Term Investments	0	1.62	1.58	1.59	0.08	0.3	0
Cash & Cash Equivalents	17.37	17.19	14.94	8.87	9.37	0.96	0.07
Cash Growth	1.06%	15.03%	68.39%	-5.34%	875.21%	1365.83%	-
Receivables	1.39	3.38	5.03	4.74	4.5	2.96	3.9
Inventory	0.53	1.02	0.86	0.89	1.01	1.27	0.89
Other Current Assets	0.23	0.86	2.41	5.13	0.71	0.91	0.05
Total Current Assets	19.52	22.45	23.23	19.64	15.59	6.1	4.91
Property, Plant & Equipment	1.27	1.59	1.79	1.9	1.81	1.49	0.49
Goodwill and Intangibles	0.03	0.04	0.05	0.05	0.06	0.06	0.04
Other Long-Term Assets	8.74	9.46	9.48	0.11	0.01	0.01	0
Total Long-Term Assets	10.03	11.09	11.31	2.07	1.88	1.56	0.53
Total Assets	29.55	33.55	34.55	21.7	17.47	7.66	5.43
Accounts Payable	1.38	1.48	1.46	1.94	1.69	2.41	1.26
Current Debt	3.39	2.05	0.04	6.69	0.26	0.39	0.3
Other Current Liabilities	9.73	13.59	17.09	3.64	4.37	1.58	2.01
Total Current Liabilities	14.5	17.12	18.58	12.26	6.32	4.37	3.58
Long-Term Debt	0.37	0	0.01	0.04	0.04	0	0
Total Long-Term Liabilities	0.37	0	0.01	0.04	0.04	0	0
Total Liabilities	14.86	17.12	18.59	12.3	6.36	4.37	3.58
Total Debt	3.76	2.05	0.04	6.72	0.3	0.39	0.3
Debt Growth	83.58%	4613.57%	-99.35%	2120.13%	-21.36%	27.45%	-
Retained Earnings	-21.61	-15.69	-9.95	-7.2	3.08	1.54	0.36
Comprehensive Income	-0.2	0.96	0.53	-0.59	0.05	0.26	0.01
Shareholders' Equity	14.69	16.42	15.96	9.4	11.11	3.29	1.85
Net Cash / Debt	13.61	15.14	14.9	2.15	9.07	0.58	-0.24
Net Cash / Debt Growth	-10.09%	1.63%	593.38%	-76.31%	1474.64%	-	-
Net Cash Per Share	50.99	364.02	517.57	173.76	881.99	57.60	-23.66
Working Capital	5.02	5.33	4.65	7.37	9.27	1.73	1.33
Book Value Per Share	55.03	394.91	554.56	760.36	1080.07	328.58	185.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).